LivaNova (LIVN) Other Non-Current Liabilities (2015 - 2026)
LivaNova (LIVN) reported Other Non-Current Liabilities of $54.4 million for Q1 2026, up 14.98% on a YoY basis from $47.3 million in Q1 2025, and up 29.34% sequentially from $42.0 million in Q4 2025.
LivaNova (LIVN) Other Non-Current Liabilities (2015 - 2026) Analysis & Trends
LivaNova (LIVN) has 12 years of Other Non-Current Liabilities data on file, last reported at $54.4 million in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Liabilities rose 14.98% year-over-year to $54.4 million; the trailing twelve-month figure through Mar 2026 stood at $54.4 million (up 14.98% YoY), and the FY2025 full-year result was $42.0 million, down 5.47% from the prior year.
- Other Non-Current Liabilities advanced to $54.4 million in Q1 2026, from $42.0 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $104.9 million in Q1 2024 to a low of $39.7 million in Q2 2025.
- A 5-year average of $59.8 million and a median of $47.3 million in 2025 frame the typical range for Other Non-Current Liabilities.
- Across the five-year window, Other Non-Current Liabilities plunged 59.28% in 2022 and jumped 126.76% in 2024, its largest moves.
- Tracing LIVN's Other Non-Current Liabilities over 5 years: stood at $85.3 million in 2022, then decreased by 5.15% to $80.9 million in 2023, then slumped by 45.02% to $44.5 million in 2024, then dropped by 5.47% to $42.0 million in 2025, then rose by 29.34% to $54.4 million in 2026.
- Business Quant data shows LIVN's Other Non-Current Liabilities at $54.4 million in Q1 2026, $42.0 million in Q4 2025, and $64.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | LivaNova | 4.30 Bn | 3.76 Bn | 243.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 54.38 Mn |
| Dec 31, 2025 | 42.05 Mn |
| Sep 30, 2025 | 64.52 Mn |
| Jun 30, 2025 | 39.66 Mn |
| Mar 31, 2025 | 47.29 Mn |
| Dec 31, 2024 | 44.48 Mn |
| Sep 30, 2024 | 47.04 Mn |
| Jun 30, 2024 | 81.17 Mn |
| Mar 31, 2024 | 104.92 Mn |
| Dec 31, 2023 | 80.90 Mn |
| Sep 30, 2023 | 46.26 Mn |
| Jun 30, 2023 | 92.63 Mn |
| Mar 31, 2023 | 46.27 Mn |
| Dec 31, 2022 | 85.29 Mn |
| Sep 30, 2022 | 42.39 Mn |
| Jun 30, 2022 | 47.19 Mn |
| Mar 31, 2022 | 49.77 Mn |
| Dec 31, 2021 | 86.83 Mn |
| Sep 30, 2021 | 104.08 Mn |
| Jun 30, 2021 | 97.05 Mn |